Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MOHIT KHERA and MOHIT KHERA.
MOHIT KHERA
Connection Strength
69.028
MOHIT KHERA
  1. Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024). Sex Med Rev. 2025 Oct 04; 13(4):548-573.
    View in: PubMed
    Score: 0.997
  2. Trends in blood-based metabolic and cardiovascular risk profiles in men during treatment for testosterone deficiency: a longitudinal, retrospective cohort study. J Sex Med. 2025 Sep 04; 22(9):1564-1571.
    View in: PubMed
    Score: 0.991
  3. Sexual Health. J Urol. 2025 Sep 02; 101097JU0000000000004721.
    View in: PubMed
    Score: 0.991
  4. Sexual Health. J Urol. 2025 Nov; 214(5):550-552.
    View in: PubMed
    Score: 0.985
  5. Long-term testosterone pellet insertion in women with low libido shows no evidence of erythrocytosis and a minimal side effect profile. Transl Androl Urol. 2025 Jul 30; 14(7):1842-1848.
    View in: PubMed
    Score: 0.984
  6. Testosterone deficiency and treatments: common misconceptions and practical guidance for patient care. Sex Med Rev. 2025 Jul 03; 13(3):373-380.
    View in: PubMed
    Score: 0.979
  7. Transcutaneous electrical neural stimulation in patients with erectile dysfunction: a single arm pilot study. J Sex Med. 2025 05 10; 22(5):971-972.
    View in: PubMed
    Score: 0.969
  8. Exploring the Impact of a Masters of Business Administration on Urologists' Careers. Urology. 2025 Sep; 203:42-46.
    View in: PubMed
    Score: 0.963
  9. Testosterone replacement therapy in men on active surveillance for prostate cancer. J Sex Med. 2025 04 08; 22(3):432-438.
    View in: PubMed
    Score: 0.963
  10. Video discharge instructions increase patient understanding for office-based procedures: a randomized controlled study. Transl Androl Urol. 2025 Mar 30; 14(3):678-684.
    View in: PubMed
    Score: 0.961
  11. Newer formulations of oral testosterone undecanoate: development and liver side effects. Sex Med Rev. 2025 Jan 31; 13(1):33-40.
    View in: PubMed
    Score: 0.951
  12. Erectile dysfunction as a holistic indicator of well-being: a narrative review. Sex Med Rev. 2025 Jan 31; 13(1):11-19.
    View in: PubMed
    Score: 0.951
  13. Editorial Comment on "Rethinking Low Testosterone in Older Men: Association With Obesity Rather Than Aging". Urology. 2025 Apr; 198:213-214.
    View in: PubMed
    Score: 0.951
  14. Sexspan: a comprehensive framework for sustaining lifelong sexual health and vitality. J Sex Med. 2025 01 03; 22(1):4-6.
    View in: PubMed
    Score: 0.946
  15. Regenerative therapies for erectile dysfunction: a systematic review, Bayesian network meta-analysis, and meta-regression. J Sex Med. 2024 12 01; 21(12):1152-1158.
    View in: PubMed
    Score: 0.940
  16. Development of a new Peyronie's disease self-assessment screening app. Transl Androl Urol. 2024 Nov 30; 13(11):2617-2624.
    View in: PubMed
    Score: 0.940
  17. Lessons learned from the Sexual Medicine Society of North America fellowship bootcamp. J Sex Med. 2024 09 28; 21(10):961-966.
    View in: PubMed
    Score: 0.929
  18. Advancements in ectopic reservoir placement for inflatable penile prostheses. Sex Med Rev. 2024 Sep 25; 12(4):770-781.
    View in: PubMed
    Score: 0.928
  19. Safety and efficacy of enclomiphene and clomiphene for hypogonadal men. Transl Androl Urol. 2024 Sep 30; 13(9):1984-1990.
    View in: PubMed
    Score: 0.928
  20. Lessons learned from the TRAVERSE trial. J Sex Med. 2024 09 03; 21(9):746-748.
    View in: PubMed
    Score: 0.925
  21. Long-Term Satisfaction With Collagenase Clostridium Histolyticum for Peyronie's Disease: Clinical Predictors and Side Effect Profile. Urol Pract. 2025 01; 12(1):168-175.
    View in: PubMed
    Score: 0.925
  22. Sexual Medicine Society of North America (SMSNA)/American Urological Association (AUA) telemedicine and men's health white paper. J Sex Med. 2024 03 28; 21(4):318-332.
    View in: PubMed
    Score: 0.897
  23. Optimizing sexual reproductive health of men and women with cystic fibrosis: A systematic review. J Cyst Fibros. 2024 Jul; 23(4):633-638.
    View in: PubMed
    Score: 0.888
  24. First-time orgasm in a young man with lifelong anorgasmia after flibanserin use: a case report. Sex Med. 2023 Dec; 11(6):qfad066.
    View in: PubMed
    Score: 0.884
  25. Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2024 Sep; 27(3):507-519.
    View in: PubMed
    Score: 0.883
  26. Stem cell therapy for erectile dysfunction: a systematic review. Sex Med Rev. 2023 12 23; 12(1):87-93.
    View in: PubMed
    Score: 0.881
  27. Hyperbaric oxygen therapy as a treatment for erectile dysfunction: a meta-analysis. Sex Med Rev. 2023 12 23; 12(1):94-99.
    View in: PubMed
    Score: 0.881
  28. Will you go the distance? A satisfaction survey of telemedicine in sexual medicine. Sex Med. 2023 Dec; 11(6):qfad060.
    View in: PubMed
    Score: 0.880
  29. Effect of aerobic exercise on erectile function: systematic review and meta-analysis of randomized controlled trials. J Sex Med. 2023 11 30; 20(12):1369-1375.
    View in: PubMed
    Score: 0.877
  30. Implantable Penile Prosthesis for Erectile Dysfunction: Insurance Coverage in the United States. Urol Pract. 2023 09; 10(5):501-510.
    View in: PubMed
    Score: 0.860
  31. Quantifying the number of US men with erectile dysfunction who are potential candidates for penile prosthesis implantation. Sex Med. 2023 Apr; 11(2):qfad010.
    View in: PubMed
    Score: 0.840
  32. The Low Submuscular Reservoir Placement With Transfascial Fixation for Inflatable Penile Prostheses. J Sex Med. 2022 08; 19(8):1309-1312.
    View in: PubMed
    Score: 0.793
  33. Testosterone replacement therapy and cardiovascular disease. Int J Impot Res. 2022 Nov; 34(7):685-690.
    View in: PubMed
    Score: 0.769
  34. The Potential for Pharmacological Interventions for Low Sex Drive in Men. J Sex Med. 2022 02; 19(2):165-169.
    View in: PubMed
    Score: 0.769
  35. Ectopic low submuscular pressure regulating balloon placement with transfascial fixation for artificial urinary sphincter. Can J Urol. 2021 12; 28(6):10936-10940.
    View in: PubMed
    Score: 0.764
  36. Differential Gene Expression in Post-Finasteride Syndrome Patients. J Sex Med. 2021 09; 18(9):1479-1490.
    View in: PubMed
    Score: 0.743
  37. Testosterone's Role in COVID-19. J Sex Med. 2021 05; 18(5):843-848.
    View in: PubMed
    Score: 0.727
  38. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk. J Sex Med. 2021 01; 18(1):83-98.
    View in: PubMed
    Score: 0.714
  39. Controversies in Testosterone Therapy. Sex Med Rev. 2021 01; 9(1):149-159.
    View in: PubMed
    Score: 0.714
  40. Is there still a place for malleable penile implants in the United States? Wilson's Workshop #18. Int J Impot Res. 2023 Mar; 35(2):82-89.
    View in: PubMed
    Score: 0.713
  41. Hypogonadism management and cardiovascular health. Postgrad Med. 2020 Dec; 132(sup4):35-41.
    View in: PubMed
    Score: 0.707
  42. Controversies with testosterone therapy. Can J Urol. 2020 08; 27(S3):20-23.
    View in: PubMed
    Score: 0.696
  43. Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia. Transl Androl Urol. 2020 Jun; 9(3):1201-1209.
    View in: PubMed
    Score: 0.688
  44. Bipolar Androgen Therapy in Prostate Cancer (Update). J Sex Med. 2020 05; 17(5):831-834.
    View in: PubMed
    Score: 0.673
  45. A Critique of the AUA Guidelines on Testosterone Deficiency. J Sex Med. 2020 04; 17(4):561-564.
    View in: PubMed
    Score: 0.665
  46. Editorial Comment. J Urol. 2019 09; 202(3):610.
    View in: PubMed
    Score: 0.650
  47. An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress? Eur Urol Focus. 2019 Jul; 5(4):536-538.
    View in: PubMed
    Score: 0.643
  48. Effect of Body Weight on Sexual Function in Men and Women. Curr Sex Health Rep. 2019 Mar; 11(1):52-59.
    View in: PubMed
    Score: 0.626
  49. Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male. Eur Urol Focus. 2018 04; 4(3):321-323.
    View in: PubMed
    Score: 0.608
  50. The Role of Testosterone Therapy in the Setting of Prostate Cancer. Curr Urol Rep. 2018 Jun 30; 19(8):67.
    View in: PubMed
    Score: 0.602
  51. Penile Prosthesis Implantation in Patients With Peyronie's Disease: Results of the PROPPER Study Demonstrates a Decrease in Patient-Reported Depression. J Sex Med. 2018 05; 15(5):786-788.
    View in: PubMed
    Score: 0.593
  52. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. J Sex Med. 2018 02; 15(2):148-158.
    View in: PubMed
    Score: 0.586
  53. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes. Med Clin North Am. 2018 Mar; 102(2):361-372.
    View in: PubMed
    Score: 0.579
  54. Alternatives to Testosterone Therapy: A Review. Sex Med Rev. 2018 01; 6(1):106-113.
    View in: PubMed
    Score: 0.578
  55. Testosterone therapy improves erectile function and libido in hypogonadal men. Curr Opin Urol. 2017 Nov; 27(6):511-515.
    View in: PubMed
    Score: 0.576
  56. Testosterone inhibits the growth of prostate cancer xenografts in nude mice. BMC Cancer. 2017 Sep 07; 17(1):635.
    View in: PubMed
    Score: 0.570
  57. Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies. Transl Androl Urol. 2017 Feb; 6(1):28-36.
    View in: PubMed
    Score: 0.546
  58. Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population. J Sex Med. 2017 01; 14(1):88-97.
    View in: PubMed
    Score: 0.541
  59. Testosterone therapy and prostate cancer. Transl Androl Urol. 2016 Dec; 5(6):909-920.
    View in: PubMed
    Score: 0.540
  60. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM?2015). J Sex Med. 2016 12; 13(12):1787-1804.
    View in: PubMed
    Score: 0.540
  61. Editorial Comment on "Couple-Based Psychosexual Support Following Prostate Cancer Surgery: Results of a Feasibility Pilot Randomized Control Trial". J Sex Med. 2016 08; 13(8):1243-4.
    View in: PubMed
    Score: 0.528
  62. Adult-Onset Hypogonadism. Mayo Clin Proc. 2016 07; 91(7):908-26.
    View in: PubMed
    Score: 0.524
  63. Testosterone Therapies. Urol Clin North Am. 2016 May; 43(2):185-93.
    View in: PubMed
    Score: 0.514
  64. Male hormones and men's quality of life. Curr Opin Urol. 2016 Mar; 26(2):152-7.
    View in: PubMed
    Score: 0.513
  65. Testosterone is Protective against Cardiac Disease: Pro. J Urol. 2016 04; 195(4 Pt 1):831-2.
    View in: PubMed
    Score: 0.509
  66. Changing paradigm of men's health. Indian J Urol. 2016 Jan-Mar; 32(1):5.
    View in: PubMed
    Score: 0.507
  67. The Evolution of the Inflatable Penile Prosthesis Reservoir and Surgical Placement. J Sex Med. 2015 Nov; 12 Suppl 7:464-7.
    View in: PubMed
    Score: 0.501
  68. Testosterone Replacement in Men with Treated and Untreated Prostate Cancer. Sex Med Rev. 2013 Oct; 1(3):143-149.
    View in: PubMed
    Score: 0.500
  69. Testosterone Therapy for Female Sexual Dysfunction. Sex Med Rev. 2015 Jul; 3(3):137-144.
    View in: PubMed
    Score: 0.499
  70. Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer. Asian J Androl. 2015 Sep-Oct; 17(5):807-10.
    View in: PubMed
    Score: 0.495
  71. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. J Urol. 2015 Nov; 194(5):1271-6.
    View in: PubMed
    Score: 0.486
  72. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med. 2015 May; 12(5):1105-6.
    View in: PubMed
    Score: 0.484
  73. Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis. J Sex Med. 2015 Apr; 12(4):975-84.
    View in: PubMed
    Score: 0.478
  74. Controversies in testosterone supplementation therapy. Asian J Androl. 2015 Mar-Apr; 17(2):175-6.
    View in: PubMed
    Score: 0.478
  75. RE: Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology. 2015 Jan; 156(1):L1-2.
    View in: PubMed
    Score: 0.473
  76. Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro. Asian J Androl. 2014 Nov-Dec; 16(6):864-8.
    View in: PubMed
    Score: 0.467
  77. Alternative treatment modalities for the hypogonadal patient. Curr Urol Rep. 2014 Jul; 15(7):417.
    View in: PubMed
    Score: 0.457
  78. Reply to Julia Klap and Kevin R. Loughlin's letter to the editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23. Eur Urol. 2014 Aug; 66(2):e33.
    View in: PubMed
    Score: 0.452
  79. Controversies in the treatment of male hypogonadism. Urology. 2014 Apr; 83(4):957.
    View in: PubMed
    Score: 0.449
  80. Patients with testosterone deficit syndrome and depression. Arch Esp Urol. 2013 Sep; 66(7):729-36.
    View in: PubMed
    Score: 0.431
  81. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014 Jan; 65(1):115-23.
    View in: PubMed
    Score: 0.430
  82. Nitric oxide-releasing polymeric microspheres improve diabetes-related erectile dysfunction. J Sex Med. 2013 Aug; 10(8):1915-25.
    View in: PubMed
    Score: 0.424
  83. 12-month observation of testosterone replacement effectiveness in a general population of men. Postgrad Med. 2013 Mar; 125(2):8-18.
    View in: PubMed
    Score: 0.416
  84. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44.
    View in: PubMed
    Score: 0.415
  85. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med. 2013 Feb; 10(2):562-9.
    View in: PubMed
    Score: 0.405
  86. Testosterone replacement in normal and pathologic prostate. Horm Mol Biol Clin Investig. 2012 Oct; 11(3):347-53.
    View in: PubMed
    Score: 0.405
  87. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012 Sep-Oct; 33(5):927-37.
    View in: PubMed
    Score: 0.389
  88. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). Aging Male. 2012 Mar; 15(1):14-21.
    View in: PubMed
    Score: 0.381
  89. Subcutaneous implantable testosterone pellets overcome noncompliance in adolescents with Klinefelter syndrome. J Androl. 2012 Jul-Aug; 33(4):570-3.
    View in: PubMed
    Score: 0.377
  90. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011 Nov; 8(11):3204-13.
    View in: PubMed
    Score: 0.374
  91. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory. J Urol. 2011 Sep; 186(3):1005-11.
    View in: PubMed
    Score: 0.372
  92. Erectile dysfunction. BMJ Clin Evid. 2011 Jun 29; 2011.
    View in: PubMed
    Score: 0.371
  93. Testosterone therapy in men with untreated prostate cancer. J Urol. 2011 Apr; 185(4):1256-60.
    View in: PubMed
    Score: 0.362
  94. Revision of penile prosthesis surgery after use of penile traction therapy to increase erect penile length: case report and review of the literature. J Sex Med. 2011 Feb; 8(2):607-11.
    View in: PubMed
    Score: 0.356
  95. Androgen replacement therapy after prostate cancer treatment. Curr Urol Rep. 2010 Nov; 11(6):393-9.
    View in: PubMed
    Score: 0.354
  96. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med. 2010 Nov; 7(11):3659-65.
    View in: PubMed
    Score: 0.350
  97. Testosterone replacement therapy following radical prostatectomy. J Sex Med. 2009 Apr; 6(4):1165-1170.
    View in: PubMed
    Score: 0.313
  98. Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men. J Sex Med. 2009 Mar; 6 Suppl 3:234-8.
    View in: PubMed
    Score: 0.313
  99. Evolving approach to the varicocele. Urol Clin North Am. 2008 May; 35(2):183-9, viii.
    View in: PubMed
    Score: 0.298
  100. The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am. 2007 Nov; 34(4):549-53, vi.
    View in: PubMed
    Score: 0.288
  101. The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats. BJU Int. 2007 Feb; 99(2):442-6.
    View in: PubMed
    Score: 0.273
  102. Can preoperative behavioral training reduce postprostatectomy incontinence? Nat Clin Pract Urol. 2006 Jun; 3(6):302-3.
    View in: PubMed
    Score: 0.261
  103. In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology. 2005 Jul; 66(1):208-12.
    View in: PubMed
    Score: 0.245
  104. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int. 2004 Dec; 45(7):987-93.
    View in: PubMed
    Score: 0.235
  105. Botulinum toxin type A: a novel approach to the treatment of recurrent urethral strictures. J Urol. 2004 Aug; 172(2):574-5.
    View in: PubMed
    Score: 0.230
  106. Exploring the link between muscle quality and erectile dysfunction: assessing the impact of mass and strength. Sex Med Rev. 2025 Oct 04; 13(4):643-651.
    View in: PubMed
    Score: 0.062
  107. Exploring perspectives on current rules denying testosterone replacement therapy for testosterone deficient female competitive athletes: a survey study. J Sex Med. 2025 06 29; 22(7):1298-1300.
    View in: PubMed
    Score: 0.061
  108. Wearable penile devices: the TechRing. Transl Androl Urol. 2025 Jan 31; 14(1):152-157.
    View in: PubMed
    Score: 0.059
  109. Penile constriction devices: a randomized survey study to compare preferences between two medical-grade devices. J Sex Med. 2025 01 03; 22(1):43-50.
    View in: PubMed
    Score: 0.059
  110. Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism. Andrology. 2025 May; 13(4):882-893.
    View in: PubMed
    Score: 0.058
  111. Can semen analysis be utilized as a screening tool for overall health in young men? Int J Impot Res. 2025 Aug; 37(8):583-586.
    View in: PubMed
    Score: 0.057
  112. Changes in post-transplant serum testosterone levels in men undergoing lung transplantation: a pilot study using the TriNetX Research Network. Int J Impot Res. 2025 Aug; 37(8):595-600.
    View in: PubMed
    Score: 0.057
  113. Cosmetic penile enhancement procedures: an SMSNA position statement. J Sex Med. 2024 05 28; 21(6):573-578.
    View in: PubMed
    Score: 0.057
  114. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. J Clin Endocrinol Metab. 2024 Jan 18; 109(2):569-580.
    View in: PubMed
    Score: 0.055
  115. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 12 01; 6(12):e2348692.
    View in: PubMed
    Score: 0.055
  116. Reply by Authors. Urol Pract. 2023 07; 10(4):326.
    View in: PubMed
    Score: 0.053
  117. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 07 13; 389(2):107-117.
    View in: PubMed
    Score: 0.053
  118. Increasing Role of the Advanced Practice Provider in Men's Health Clinics: An Analysis of Medicare and Commercial Claims in the United States. Urol Pract. 2023 07; 10(4):320-325.
    View in: PubMed
    Score: 0.053
  119. Oral testosterone therapy: past, present, and future. Sex Med Rev. 2023 04 03; 11(2):124-138.
    View in: PubMed
    Score: 0.052
  120. Recognizing the True Value of Testosterone Therapy in Health Care. Androg Clin Res Ther. 2022; 3(1):217-223.
    View in: PubMed
    Score: 0.051
  121. Is urgent surgical management necessary for priapism in pediatric patients with hematologic conditions? J Pediatr Urol. 2022 08; 18(4):528.e1-528.e6.
    View in: PubMed
    Score: 0.050
  122. Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007-2015. Cancer Epidemiol. 2022 08; 79:102172.
    View in: PubMed
    Score: 0.049
  123. Long-Term Survival Rates of Inflatable Penile Prostheses: Systematic Review and Meta-Analysis. Urology. 2022 08; 166:6-10.
    View in: PubMed
    Score: 0.049
  124. A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism. Andrology. 2022 05; 10(4):669-676.
    View in: PubMed
    Score: 0.048
  125. Current strategies to improve erectile function in patients undergoing radical prostatectomy - preoperative scenario. Urol Oncol. 2022 03; 40(3):72-78.
    View in: PubMed
    Score: 0.048
  126. Current strategies to improve erectile function in patients undergoing radical prostatectomy - postoperative scenario. Urol Oncol. 2022 03; 40(3):87-94.
    View in: PubMed
    Score: 0.048
  127. Current strategies to improve erectile function in patients undergoing radical prostatectomy-intraoperative scenario. Urol Oncol. 2022 03; 40(3):79-86.
    View in: PubMed
    Score: 0.048
  128. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Int J Risk Saf Med. 2022; 33(1):65-76.
    View in: PubMed
    Score: 0.048
  129. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. Am Heart J. 2022 03; 245:41-50.
    View in: PubMed
    Score: 0.048
  130. Comparative assessment of outcomes and adverse effects using two different intramuscular testosterone therapy regimens: 100?mg IM weekly or 200?mg IM biweekly. Int J Impot Res. 2022 Sep; 34(6):558-563.
    View in: PubMed
    Score: 0.046
  131. Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men. J Cardiovasc Pharmacol Ther. 2021 11; 26(6):630-637.
    View in: PubMed
    Score: 0.046
  132. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer. Cancer Causes Control. 2021 Sep; 32(9):965-976.
    View in: PubMed
    Score: 0.046
  133. Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A. Can Urol Assoc J. 2021 May; 15(5):E234-E243.
    View in: PubMed
    Score: 0.046
  134. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men. Cancer Prev Res (Phila). 2021 07; 14(7):719-728.
    View in: PubMed
    Score: 0.046
  135. The Emerging Critical Role of Telemedicine in the Urology Clinic: A Practical Guide. Sex Med Rev. 2021 04; 9(2):289-295.
    View in: PubMed
    Score: 0.045
  136. Unilateral Corporal Cavernosum Partial Thrombosis: A Challenging Presentation and Management. Urology. 2021 06; 152:12-14.
    View in: PubMed
    Score: 0.045
  137. Testosterone Therapy After Prostate Cancer Treatment: A Review of Literature. Sex Med Rev. 2021 07; 9(3):393-405.
    View in: PubMed
    Score: 0.045
  138. Is treatment of hypogonadism safe for men after a solid organ transplant? Results from a retrospective controlled cohort study. Int J Impot Res. 2022 Jan; 34(1):50-54.
    View in: PubMed
    Score: 0.044
  139. Response to Commentary on Contemporary Considerations in a Man With Low Sex Drive. J Sex Med. 2020 11; 17(11):2311.
    View in: PubMed
    Score: 0.044
  140. Novel Treatments of Erectile Dysfunction: Review of the Current Literature. Sex Med Rev. 2021 01; 9(1):123-132.
    View in: PubMed
    Score: 0.043
  141. Contemporary Considerations in the Pathophysiology of Low Sex Drive in Men. J Sex Med. 2020 06; 17(6):1049-1052.
    View in: PubMed
    Score: 0.042
  142. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database. Clin Endocrinol (Oxf). 2019 12; 91(6):885-891.
    View in: PubMed
    Score: 0.041
  143. Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers. 2019 May 30; 5(1):38.
    View in: PubMed
    Score: 0.040
  144. Erectile Dysfunction: AUA Guideline. J Urol. 2018 09; 200(3):633-641.
    View in: PubMed
    Score: 0.037
  145. Caffeine intake is not associated with serum testosterone levels in adult men: cross-sectional findings from the NHANES 1999-2004 and 2011-2012. Aging Male. 2019 Mar; 22(1):45-54.
    View in: PubMed
    Score: 0.037
  146. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk. Clin Endocrinol (Oxf). 2018 07; 89(1):3-10.
    View in: PubMed
    Score: 0.037
  147. Inflatable penile prosthesis implant length with baseline characteristic correlations: preliminary analysis of the PROPPER study. Transl Androl Urol. 2017 Dec; 6(6):1167-1174.
    View in: PubMed
    Score: 0.036
  148. Recent advances in the treatment of erectile dysfunction. Postgrad Med J. 2017 Nov; 93(1105):679-685.
    View in: PubMed
    Score: 0.035
  149. Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members. Urology. 2017 Aug; 106:87-95.
    View in: PubMed
    Score: 0.035
  150. Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):285-296.
    View in: PubMed
    Score: 0.034
  151. Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):297-315.
    View in: PubMed
    Score: 0.034
  152. Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction. J Sex Med. 2016 08; 13(8):1183-98.
    View in: PubMed
    Score: 0.033
  153. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016 Apr; 13(4):465-88.
    View in: PubMed
    Score: 0.032
  154. Diagnosing secondary hypogonadism: important consequences for fertility and reversibility. BJU Int. 2016 Apr; 117(4):552-4.
    View in: PubMed
    Score: 0.031
  155. The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data. J Urol. 2016 Feb; 195(2):427-33.
    View in: PubMed
    Score: 0.031
  156. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen. Sex Med. 2015 Sep; 3(3):165-73.
    View in: PubMed
    Score: 0.031
  157. Peyronie's Disease: AUA Guideline. J Urol. 2015 Sep; 194(3):745-53.
    View in: PubMed
    Score: 0.030
  158. The nanochannel delivery system for constant testosterone replacement therapy. J Sex Med. 2015 Jun; 12(6):1375-80.
    View in: PubMed
    Score: 0.030
  159. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015 Feb; 90(2):224-51.
    View in: PubMed
    Score: 0.030
  160. Delivering enhanced testosterone replacement therapy through nanochannels. Adv Healthc Mater. 2015 Feb 18; 4(3):446-51.
    View in: PubMed
    Score: 0.029
  161. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014 Nov; 11(11):2764-71.
    View in: PubMed
    Score: 0.029
  162. The safety of testosterone supplementation therapy in prostate cancer. Nat Rev Urol. 2014 Sep; 11(9):526-30.
    View in: PubMed
    Score: 0.029
  163. Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014 Jul; 11(7):1636-45.
    View in: PubMed
    Score: 0.028
  164. North American consensus document on infection of penile prostheses. Urology. 2013 Oct; 82(4):937-42.
    View in: PubMed
    Score: 0.027
  165. Current opinions on alternative reservoir placement for inflatable penile prosthesis among members of the Sexual Medicine Society of North America. J Sex Med. 2013 Aug; 10(8):2115-20.
    View in: PubMed
    Score: 0.026
  166. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry. Postgrad Med. 2013 Mar; 125(2):19-29.
    View in: PubMed
    Score: 0.026
  167. The treatment of hypogonadism in?men of reproductive age. Fertil Steril. 2013 Mar 01; 99(3):718-24.
    View in: PubMed
    Score: 0.026
  168. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging. 2012; 7:321-30.
    View in: PubMed
    Score: 0.025
  169. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS). Pain Med. 2012 May; 13(5):688-98.
    View in: PubMed
    Score: 0.025
  170. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(?)) insertion. J Sex Med. 2012 Feb; 9(2):594-601.
    View in: PubMed
    Score: 0.024
  171. Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocr Disord. 2011 Nov 01; 11:18.
    View in: PubMed
    Score: 0.024
  172. Favorable female sexual function is associated with patient satisfaction after inflatable penile prosthesis implantation. J Sex Med. 2011 Jul; 8(7):1996-2001.
    View in: PubMed
    Score: 0.023
  173. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency. Postgrad Med. 2011 May; 123(3):17-27.
    View in: PubMed
    Score: 0.023
  174. Reply by authors. J Urol. 2010 Jun; 183(6):2315.
    View in: PubMed
    Score: 0.021
  175. Varicocele repair in patients with nonobstructive azoospermia: a meta-analysis. J Urol. 2010 Jun; 183(6):2309-15.
    View in: PubMed
    Score: 0.021
  176. Percutaneous treatment of varicocele with microcoil embolization: comparison of treatment outcome with laparoscopic varicocelectomy. Vascular. 2009 Nov-Dec; 17 Suppl 3:S129-36.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.